Literature DB >> 20852216

The unique predisposition to criminal violations in frontotemporal dementia.

Mario F Mendez1.   

Abstract

Brain disorders can lead to criminal violations. Patients with frontotemporal dementia (FTD) are particularly prone to sociopathic behavior while retaining knowledge of their acts and of moral and conventional rules. This report describes four FTD patients who committed criminal violations in the presence of clear consciousness and sufficiently intact cognition. They understood the nature of their acts and the potential consequences, but did not feel sufficiently concerned to be deterred. FTD involves a unique pathologic combination affecting the ventromedial prefrontal cortex, with altered moral feelings, right anterior temporal loss of emotional empathy, and orbitofrontal changes with disinhibited, compulsive behavior. These case histories and the literature indicate that those with right temporal FTD retain the capacity to tell right from wrong but have the slow and insidious loss of the capacity for moral rationality. Patients with early FTD present a challenge to the criminal justice system to consider alterations in moral cognition before ascribing criminal responsibility.

Entities:  

Mesh:

Year:  2010        PMID: 20852216      PMCID: PMC3139561     

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  42 in total

1.  The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia.

Authors:  P Mychack; J H Kramer; K B Boone; B L Miller
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

2.  Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region.

Authors:  J Barrash; D Tranel; S W Anderson
Journal:  Dev Neuropsychol       Date:  2000       Impact factor: 2.253

3.  How (and where) does moral judgment work?

Authors:  Joshua Greene; Jonathan Haidt
Journal:  Trends Cogn Sci       Date:  2002-12-01       Impact factor: 20.229

4.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia.

Authors:  H J Rosen; M L Gorno-Tempini; W P Goldman; R J Perry; N Schuff; M Weiner; R Feiwell; J H Kramer; B L Miller
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

5.  An investigation of moral judgement in frontotemporal dementia.

Authors:  Mario F Mendez; Eric Anderson; Jill S Shapira
Journal:  Cogn Behav Neurol       Date:  2005-12       Impact factor: 1.600

6.  Neurologic abnormalities in murderers.

Authors:  P Y Blake; J H Pincus; C Buckner
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

7.  Impairment of social and moral behavior related to early damage in human prefrontal cortex.

Authors:  S W Anderson; A Bechara; H Damasio; D Tranel; A R Damasio
Journal:  Nat Neurosci       Date:  1999-11       Impact factor: 24.884

8.  Structural anatomy of empathy in neurodegenerative disease.

Authors:  Katherine P Rankin; Maria Luisa Gorno-Tempini; Stephen C Allison; Christine M Stanley; Shenly Glenn; Michael W Weiner; Bruce L Miller
Journal:  Brain       Date:  2006-09-28       Impact factor: 13.501

9.  The regulatory function of self-conscious emotion: insights from patients with orbitofrontal damage.

Authors:  Jennifer S Beer; Erin A Heerey; Dacher Keltner; Donatella Scabini; Robert T Knight
Journal:  J Pers Soc Psychol       Date:  2003-10

10.  Frontal lobe dementia and motor neuron disease.

Authors:  D Neary; J S Snowden; D M Mann; B Northen; P J Goulding; N Macdermott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

View more
  18 in total

1.  Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman.

Authors:  Baber K Khan; Josh D Woolley; Steven Chao; Tricia See; Anna M Karydas; Bruce L Miller; Katherine P Rankin
Journal:  Psychosomatics       Date:  2012-01-28       Impact factor: 2.386

Review 2.  Personality and social cognition in neurodegenerative disease.

Authors:  Tal Shany-Ur; Katherine P Rankin
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

3.  The neuropsychological correlates of pathological lying: evidence from behavioral variant frontotemporal dementia.

Authors:  Michele Poletti; Paolo Borelli; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

Review 4.  The behavioral variant of frontotemporal dementia: linking neuropathology to social cognition.

Authors:  Chiara Cerami; Stefano F Cappa
Journal:  Neurol Sci       Date:  2013-02-03       Impact factor: 3.307

5.  Behavioral and autonomic reactivity to moral dilemmas in frontotemporal dementia versus Alzheimer's disease.

Authors:  Sylvia S Fong; Carlos David Navarrete; Sean E Perfecto; Andrew R Carr; Elvira E Jimenez; Mario F Mendez
Journal:  Soc Neurosci       Date:  2016-05-23       Impact factor: 2.083

6.  A Review of the Role of Chronic Traumatic Encephalopathy in Criminal Court.

Authors:  Alexandra L Aaronson; Sean D Bordelon; S Jan Brakel; Helen Morrison
Journal:  J Am Acad Psychiatry Law       Date:  2020-11-24

7.  Criminal behavior in frontotemporal dementia and Alzheimer disease.

Authors:  Madeleine Liljegren; Georges Naasan; Julia Temlett; David C Perry; Katherine P Rankin; Jennifer Merrilees; Lea T Grinberg; William W Seeley; Elisabet Englund; Bruce L Miller
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

8.  The Neuropsychiatric Features of Behavioral Variant Frontotemporal Dementia.

Authors:  Bradley T Peet; Sheila Castro-Suarez; Bruce L Miller
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Empathic fear responses in mice are triggered by recognition of a shared experience.

Authors:  Jeff Sanders; Mark Mayford; Dilip Jeste
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 10.  Neurodegeneration behind bars: from molecules to jurisprudence.

Authors:  Adonis Sfera; Carolina Osorio; Roberto Gradini; Amy Price
Journal:  Front Psychiatry       Date:  2014-08-27       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.